ZLCS: Zalicus Inc. - Summary | Jitta
Jitta Wealth
NEW
Log in
Sign up
×
Log in

Zalicus Inc.

NASDAQ:ZLCS

SummaryFactSheetFinancial
Notice
Stock data is unavailable or the company’s delisted.
Price
$11.80
Loss Chance
58.4%
0.88JITTA SCORE
88.49%Over Jitta Line
Jitta Ranking
Sorry, the data is not yet available for this stock.
HISTORICAL JITTA SCORE
Related
Sorry, the data is not yet available for this stock.
Jitta Factors
Growth Opportunity (31)
Recent Business Performance (40)
Financial Strength (0)
Return to Shareholders (0)
Competitive Advantage (0)
Jitta Signs
Revenue and EarningEarning loss detected in 2013
Operating MarginDeclined
Recent Business PerformanceEarning decline 14.66% in the last year
CapExVery High
Key Stats
Jitta Score
Jitta Line
0.88
88.49%
2.22
132.29%
n/a
n/a
COMPANY DESCRIPTION
As of July 15, 2014, Zalicus Inc. was acquired by EPIRUS Biopharmaceuticals, Inc., in a reverse merger transaction. Zalicus Inc., a biopharmaceutical company, discovers and develops novel treatments for patients suffering from pain. The company develops Z944, a novel oral T-type calcium channel blocker that has completed Phase Ib clinical studies for the treatment of pain indications. It is also engaged in research and preclinical development activities on its selective ion channel modulators targeting the Nav1.7 sodium channel for the treatment of pain. The company has collaboration agreements with Mallinckrodt Inc.; Fovea Pharmaceuticals SA; Institutes of BioMedical Research, Inc.; Amgen Inc.; and United States Army Medical Research Institute. The company was formerly known as CombinatoRx, Incorporated and changed its name to Zalicus Inc. in September 2010. Zalicus Inc. was founded in 2000 and is based in Cambridge, Massachusetts.
About UsCareersHelp CenterLibraryTermsPrivacyContact UsPress

Jitta Dot Com Co., Ltd. is the owner of the copyright of JITTA SCORE, JITTA LINE, JITTA SIGNS, JITTA FACTORS, JITTA LOSS CHANCE and JITTA RANKING. By accessing or using Jitta, you agree to comply with our Terms of Use and agree not to redistribute the information.

All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Any historical returns, backtest statistics or probability projections may not reflect future performance. Neither Jitta nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Fundamental data of companies, historical data, daily updates, financial statements, dividend data and index data are provided by S&P Global Market Intelligence. All stock prices are updated at the end of the day.